NDC 10797-995 - adequan i.m.

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 10797-995
Package NDCs from labels: 10797-995-94, 10797-995-85, 10797-995-01, 10797-995-70
Manufacturer: American Regent, Inc.
Effective date: 2026-05-21
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
adequan polysulphated glycosaminoglycan solution for injection - UK	American Regent, Inc.	2026-05-21	PRESCRIPTION ANIMAL DRUG LABEL
ADEQUAN INTRAMUSCULAIRE 500 MG/5 ML SOLUTION INJECTABLE	American Regent, Inc.	2026-05-19	PRESCRIPTION ANIMAL DRUG LABEL
Adequan i.m. - American Regent, Inc. \| Daiichi Sankyo Altrich Sari	American Regent, Inc. \| Daiichi Sankyo Altrich Sari	2024-10-07	PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
10797-995-01	Adequan i.m.	5 mL in 1 VIAL, SINGLE-USE	INJECTION, SOLUTION	5	10
10797-995-70	Adequan i.m.	7 in 1 CARTON	INJECTION, SOLUTION	7	10
10797-995-94	adequan i.m.	7 in 1 CARTON	INJECTION, SOLUTION	7	3
10797-995-94	adequan i.m.	5 mL in 1 VIAL	INJECTION, SOLUTION	5	3
10797-995-85	adequan i.m.	7 in 1 CARTON	INJECTION, SOLUTION	7	2
10797-995-85	adequan i.m.	5 mL in 1 VIAL	INJECTION, SOLUTION	5	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10797-995	ADEQUAN I.M. (POLYSULFATED GLYCOSAMINOGLYCAN) INJECTION, SOLUTION [AMERICAN REGENT, INC.]	9	2 package rows	20241009_466f2d34-b5fe-40e2-91e7-00fdbeba35bd.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
polysulfated glycosaminoglycan	ACTIVE INGREDIENT	268AW7000T	ADEQUAN I.M. (POLYSULFATED GLYCOSAMINOGLYCAN) INJECTION, SOLUTION [LUITPOLD PHARMACEUTICALS, INC.]	1
polysulfated glycosaminoglycan	ACTIVE MOIETY	268AW7000T	ADEQUAN I.M. (POLYSULFATED GLYCOSAMINOGLYCAN) INJECTION, SOLUTION [LUITPOLD PHARMACEUTICALS, INC.]	1
water	INACTIVE INGREDIENT	059QF0KO0R	ADEQUAN I.M. (POLYSULFATED GLYCOSAMINOGLYCAN) INJECTION, SOLUTION [LUITPOLD PHARMACEUTICALS, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 53 of 53 · 1,045 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sodium Chloride	SODIUM CHLORIDE	Baxter Healthcare Corporation	2a96096d-43cc-49b7-af53-b53c17f41001	2014-07-25	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
SODIUM CHLORIDE	SODIUM CHLORIDE	Baxter Healthcare Corporation	b3b4b176-41f0-4ca8-90d4-3fba5707564a	2014-02-21		Exact identifier unii: 451W47IQ8X
TIS-U-SOL	SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE	Baxter Healthcare Corporation	9da4121f-d62d-4da4-8dfb-0494da16015f	2014-02-21		Exact identifier unii: 451W47IQ8X
Ringers	SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE,	Baxter Healthcare Corporation	e1953d54-818d-46a6-8532-518ebae6d84e	2012-06-13		Exact identifier unii: 451W47IQ8X
Lactated Ringers	SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	Baxter Healthcare Corporation	f09f80bf-2f8b-4420-865d-aec2d5e5cd4d	2012-06-12		Exact identifier unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.